| Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma H Tseng, W Xiong, S Badeti, Y Yang, M Ma, T Liu, CA Ramos, G Dotti, ... Nature communications 11 (1), 4810, 2020 | 68 | 2020 |
| Superior semicircular canal dehiscence: Diagnosis and management C Mau, N Kamal, S Badeti, R Reddy, YLM Ying, RW Jyung, JK Liu Journal of Clinical Neuroscience 48, 58-65, 2018 | 61 | 2018 |
| Superior expansion and cytotoxicity of human primary NK and CAR-NK cells from various sources via enriched metabolic pathways Y Yang, S Badeti, H Tseng, MT Ma, T Liu, JG Jiang, C Liu, D Liu Molecular Therapy-Methods & Clinical Development 18, 428-445, 2020 | 37 | 2020 |
| Efficacy of targeting SARS-CoV-2 by CAR-NK cells M Ma, S Badeti, K Geng, D Liu BioRxiv, 2020.08. 11.247320, 2020 | 23 | 2020 |
| CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In Vitro MT Ma, S Badeti, CH Chen, J Kim, A Choudhary, B Honnen, C Reichman, ... Frontiers in immunology 12, 652223, 2021 | 22 | 2021 |
| The role of immunological synapse in predicting the efficacy of chimeric antigen receptor (CAR) immunotherapy D Liu, S Badeti, G Dotti, J Jiang, H Wang, J Dermody, P Soteropoulos, ... Cell communication and signaling 18 (1), 1-20, 2020 | 22 | 2020 |
| Potential role of IFN-α in COVID-19 patients and its underlying treatment options L Yang, J Wang, P Hui, TO Yarovinsky, S Badeti, K Pham, C Liu Applied Microbiology and Biotechnology 105 (10), 4005-4015, 2021 | 11 | 2021 |
| A national WestlawNext database analysis of malpractice litigation in radiation oncology AV Prabhu, TS Quang, R Funahashi, R Gupta, S Badeti, N Adeeb, ... Federal Practitioner 35 (Suppl 1), S44, 2018 | 9 | 2018 |
| Efficacy of targeting SARS-CoV-2 by CAR-NK Cells. bioRxiv 2020 M Ma, S Badeti, K Geng, D Liu Google Scholar, 0 | 6 | |
| Development of a novel human CD147 knock-in NSG mouse model to test SARS-CoV-2 viral infection S Badeti, Q Jiang, A Naghizadeh, H Tseng, Y Bushkin, SAE Marras, ... Cell & bioscience 12 (1), 1-19, 2022 | 5 | 2022 |
| Deletion of ER-retention motif on SARS-CoV-2 spike protein reduces cell hybrid during cell–cell fusion X Wang, CH Chen, S Badeti, JH Cho, A Naghizadeh, Z Wang, D Liu Cell & Bioscience 11 (1), 1-12, 2021 | 5 | 2021 |
| CAR-NK cells effectively target the D614 and G614 SARS-CoV-2-infected cells M Ma, S Badeti, CH Chen, A Pinter, Q Jiang, L Shi, R Zhou, H Xu, Q Li, ... BioRxiv, 2021.01. 14.426742, 2021 | 4 | 2021 |
| Natural Killer (NK) and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line M Ma, S Badeti, JK Kim, D Liu JoVE (Journal of Visualized Experiments), e62336, 2022 | 1 | 2022 |
| Dysfunctional Natural Killer cells expanded from a liver with Hepatocellular Carcinoma show reduced killing against a unique HCC cell line S Badeti, Y Yang, L Yang, A Luna, D Liu, C Liu The FASEB Journal 34 (S1), 1-1, 2020 | 1 | 2020 |
| S309 chimeric antigen receptors and methods of use D Liu, M Ma, S Badeti US Patent App. 17/551,006, 2022 | | 2022 |
| Cr3022 chimeric antigen receptors and methods of use D Liu, M Ma, S Badeti US Patent App. 17/399,993, 2022 | | 2022 |
| Development of a Novel Human CD147 Knock-in NSG Mouse Model to Test SARS-CoV-2 Viral Infection (preprint) S Badeti, Q Jiang, A Naghizadeh, HC Tseng, Y Bushkin, SAE Marras, ... | | 2022 |
| Heterotopic Ossification in Benign and Malignant Renal Neoplasms S Badeti, PQ Deb, D Heller, V Fitzhugh, R Weiss AMERICAN JOURNAL OF CLINICAL PATHOLOGY 156, S151-S151, 2021 | | 2021 |
| Development of a Superior Method for the Reliable Expansion of Tumor-Infiltrating Natural Killer cells from Rare Human Malignancies for the Purposes of ex vivo … S Badeti, M Ma, P Deb, A Alhatem, K Algarrahi, P Agarwalla, D Liu LABORATORY INVESTIGATION 101 (SUPPL 1), 1063-1064, 2021 | | 2021 |
| Examining cell-to-cell contacts to predict the efficacy of CAR immunotherapy D Liu, S Badeti, G Dotti, J Jiang, H Wang, J Dermody, P Soteropoulos, ... | | 2020 |
Dongfang LiuBaylor College of MedicineVerified email at rutgers.edu
